Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Editorial Enquiries – GOLD
Editorial Enquiries – EMJ
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Editorial Enquiries – GOLD
Editorial Enquiries – EMJ
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Updates in
BRAF V600E
-Mutated mCRC
9
Mins
March 2024
The BRAF V600E mutation occurs in 8–12% of patients with metastatic colorectal cancer, and is associated with poor prognosis. This…
Read more
9
Mins
19th March 2024
Updates in
BRAF V600E
-Mutated mCRC
The BRAF V600E mutation occurs in 8–12% of patients with metastatic colorectal cancer, and is associated with poor prognosis. This…
11
Mins
5th March 2024
Follow-Up Care Models Post-Cancer Treatment
After being diagnosed with cancer, patients embark on a journey that involves ongoing treatments, and regular visits to healthcare…
11
Mins
22nd February 2024
Advancements in Endometrial Cancer Research in 2023
Following the presentation of practice-changing findings from RUBY and NRG-GY018 in patients with advanced or recurrent endometrial cancer at the SGO Annual Meeting in March 2023, data presented and published through the remainder of 2023 show that research in endometrial cancer continues at a pace.
15
Mins
30th January 2024
Exploring Advancements and Challenges in Adjuvant Melanoma Treatment
Melanoma of the skin is a common type of cancer that primarily affects younger patients. In Stage III melanoma, which does not involve…
9
Mins
14th December 2023
Redefining Renal Cell Carcinoma
Renal cell carcinoma (RCC) is the most common primary tumour originating from the kidney, and accounts for more than 90% of all renal…
10
Mins
5th December 2023
Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment With Immuno-oncology and
ROS1
Tyrosine Kinase Inhibitors
The non-small cell lung cancer (NSCLC) treatment landscape has rapidly evolved over the last two decades. The addition of immuno-oncology…
10
Mins
5th December 2023
Current and Upcoming Treatment Strategies After CDK4/6 Inhibitors for Patients With ER+/HER2- Advanced Breast Cancer
The latest recommendations and upcoming treatment strategies for patients with oestrogen-receptor positive (ER+), human epidermal growth…
3
Mins
5th December 2023
Isolated Tumour Cells in Early Endometrial Carcinomas
Endometrial cancer is the most common gynaecologic malignancy in high-income countries due to increased life expectancy. Approximately…
15
Mins
5th December 2023
Improving Inclusivity and Diversity in Clinical Trials
Although clinical trials form the backbone of evidence-based medicine, cohorts participating in clinical trials are often poorly…
6
Mins
5th December 2023
Dostarlimab and Radiotherapy in A Patient with MSI-H/dMMR Endometrial Cancer
Endometrial carcinoma (EC) is the world’s most common gynaecological malignancy, with a global incidence of 382,069 new cases and 89,929…
12
Mins
1st December 2023
Food Insecurity Among Patients with Cancer
This paper explores the overlooked influence of food insecurity on cancer care, its correlation with malnutrition and poor patient…
10
Mins
8th November 2023
Disparities in the Incidence and Outcome of Endometrial Cancer: Interviews with Two Key Opinion Leaders
Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and often presents with comorbidities…
6
Mins
8th November 2023
Interview: John Marshall
You have to remember that I am a very old oncologist. So, when I first started, there was almost nothing in the world of GI cancer. I was…
11
Mins
27th October 2023
The Importance of the Multidisciplinary Team in the Management of Patients with Endometrial Cancer: Interviews with Two Key Opinion Leaders
Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and the incidence is rising significantly…
10
Mins
24th October 2023
Recent Developments in Endometrial Cancer Research Presented at the Society of Gynecologic Oncology (SGO) Annual Meeting 2023: Interviews with Two Key Opinion Leaders
Endometrial cancer is the most common gynaecological malignancy in developed countries, and often presents at an early stage. Paclitaxel…
8
Mins
12th October 2023
Effects of Obesity on Cancer Prognosis and Treatment
Obesity, defined as a BMI greater than or equal to 30 kg/m2, is a condition with rising incidence around the world that contributes…
11
Mins
2nd October 2023
Real-World Evidence of Biosimilar Utilisation and Pharmacoeconomics in People Living with Breast or Lung Cancer
As the medical community continues to explore and harness the potential of biosimilars, it is imperative to accumulate robust real-world…
6
Mins
25th August 2023
Interview: Karen Canfell
My entry point was through a field that I now still spend a lot of time in, which is cervical cancer control…
7
Mins
7th August 2023
PTEN Loss causing Dabrafenib and Trametinib Resistance in Epithelioid Glioblastoma
This case report explores a rare and aggressive variant of glioblastoma that is common in children and young adults…
8
Mins
26th July 2023
Interview: Kelly Hirko
My interest in cancer research was sparked during my experience in the Undergraduate Research Opportunity Program (UROP) as an…
10
Mins
16th March 2023
The Role of Granulocyte-Colony Stimulating Factor Biosimilars for Supportive Cancer Care: A Year in Review
Chemotherapy-induced neutropenia is a frequent, severe, adverse haematological complication of myelosuppressive and immunosuppressive cytotoxic chemotherapy treatment.
11
Mins
14th February 2023
A Review of the Latest Advancements in Ovarian Cancer Care Featured at ESMO 2022
Ovarian cancer is the seventh most commonly diagnosed cancer among females and the most lethal gynaecologic malignancy globally because of its vague presentation, insidious nature, recurrence, and drug resistance.
6
Mins
6th February 2023
Marantic Endocarditis and Lung Adenocarcinoma with Brain Metastasis
This case report aims to unveil the possible differentials and processes involved in the diagnosis of marantic endocarditis…
7
Mins
18th January 2023
Radical Radiotherapy in Sinonasal Myopericytoma
The current study reports a case of extended maxillary sinus myopericytoma, diagnosed following the development of an early bulky recurrence 3 months after surgical excision…
Loading posts...
« Previous
1
2
3
4
5
…
26
Next »